Showing results 100 to 119 of 297
< previous
next >
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Immune Checkpoint Treatment in Hepatocellular Carcinoma Proceeding/Conference:Multi-specialty Medical Mega Conference Sixth Round, Hong Kong | 2016 | ||
Immuno-oncology in current targeted therapy of mCRC treatment Proceeding/Conference:Taiwan Merck Serono Forum, Changhua, Taiwan | 2016 | ||
Immuno-Oncology in mCRC treatment: IgG1 vs. IgG2 Proceeding/Conference:Invited Lecture, Department of Surgery, Linkou Chang Gung Memorial Hospital, Taipei, Taiwan | 2016 | ||
Immunotherapy and Combinations in the Management of Advanced HCC Proceeding/Conference:The 10th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2019) | 2019 | ||
Immunotherapy for Hepacellular Carcinoma---Are We Ready for the Prime Time? Proceeding/Conference:APPLE 2016 (Asia-Pacific Primary Liver Cancer Expert Meeting 2016), Hong Kong | 2016 | ||
Immunotherapy for Advanced Hepatocellular Carcinoma: At the Dawn of a New Era Proceeding/Conference:2nd Singapore Liver Cancer Consortium (SLCC) Symposium | 2018 | ||
Immunotherapy for HCC – Are We Ready for the Prime Time? Proceeding/Conference:Liver Cancer | 2016 | ||
Immunotherapy for Hepatocellular Carcinoma: Current and Future Proceeding/Conference:50th Annual Meeting of The Gastroenterological Society of Taiwan and 29th Annual Meeting of The Digestive Endoscopy Society of Taiwan | 2020 | ||
Immunotherapy for Pancreatic Cancer: Are We There Yet? Proceeding/Conference:Asia Pacific Digestive Week, 2017 | 2017 | ||
Immunotherapy in HCC – a paradigm change Proceeding/Conference:Fifth Asia Pacific Gastroenterology Cancer Summit 2018, Singapore | 2018 | ||
Immunotherapy in Hepatocellular and Pancreatic Cancer: Hong Kong Experiences Proceeding/Conference:First Oncology Forum, Shulan Hospital, Hangzhou, China | 2018 | ||
Immunotherapy in Hepatocellular Carcinoma: an update Proceeding/Conference:3rd Singapore Liver Cancer Consortium (SLCC) Symposiium, 2019 | 2019 | ||
| 2022 | |||
| 2006 | |||
| 2014 | |||
| 2011 | |||
Intensifying taxane-carboplatin-containing neoadjuvant chemotherapy (NAC) increased response in locally advanced HER2-positive breast cancer patients with hormone receptor expression Proceeding/Conference:Global Breast Cancer Conference, GBCC 2015 | 2016 | ||
Intramuscular recurrence in a Hepatocellular carcinoma patient with indolent disease course Journal:World Journal of Surgical Oncology | 2008 | ||
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors Journal:Journal for ImmunoTherapy of Cancer | 2021 | ||
| 2012 |